# McMaster University Medical Centre

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/mcmaster-university-medical-centre/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 78 |
| Citations | 1,044,293 |
| City | Hamilton |
| Country | CA |
| Description | McMaster University Medical Centre is a research organisation in Hamilton, CA. OpenAlex records 8,623 works and 1,044,293 citations for it. 1,617 researchers list it as their most recent affiliation. |
| Homepage | http://www.hamiltonhealthsciences.ca/body.cfm?ID=232 |
| OpenAlex ID | https://openalex.org/I2801259263 |
| Region | Ontario |
| Researchers | 1,617 |
| ROR ID | https://ror.org/05jyrng31 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q6802330 |
| Works | 8,623 |

## University papers

Showing 12 of 99.

- [Effects of Intensive Glucose Lowering in Type 2 Diabetes](https://scholariq.org/papers/effects-of-intensive-glucose-lowering-in-type-2-diabetes/)
- [Edoxaban versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/edoxaban-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials](https://scholariq.org/papers/comparison-of-the-efficacy-and-safety-of-new-oral-anticoagulants-with-warfarin/)
- [Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-cardiovascular-outcomes-in-type-2-diabetes-rewind-a-double-blind/)
- [PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews](https://scholariq.org/papers/prisma-s-an-extension-to-the-prisma-statement-for-reporting-literature-searches/)
- [Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome](https://scholariq.org/papers/lixisenatide-in-patients-with-type-2-diabetes-and-acute-coronary-syndrome/)
- [The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation](https://scholariq.org/papers/the-2018-european-heart-rhythm-association-practical-guide-on-the-use-of-non/)
- [The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials](https://scholariq.org/papers/the-results-of-direct-and-indirect-treatment-comparisons-in-meta-analysis-of/)
- [Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials](https://scholariq.org/papers/cardiovascular-mortality-and-kidney-outcomes-with-glp-1-receptor-agonists-in-2/)
- [Idarucizumab for Dabigatran Reversal](https://scholariq.org/papers/idarucizumab-for-dabigatran-reversal/)
- [Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial](https://scholariq.org/papers/renal-insufficiency-as-a-predictor-of-cardiovascular-outcomes-and-the-impact-of/)
- [Intensive glucose control and macrovascular outcomes in type 2 diabetes](https://scholariq.org/papers/intensive-glucose-control-and-macrovascular-outcomes-in-type-2-diabetes/)

## University researchers

- [Lauren E. Griffith](https://scholariq.org/researchers/lauren-e-griffith/)
- [Αλεξάνδρα Παπαϊωάννου](https://scholariq.org/researchers/a5059955804/)
- [Eileen K. Hutton](https://scholariq.org/researchers/eileen-k-hutton/)
- [Rachel Couban](https://scholariq.org/researchers/rachel-couban/)
- [Lawrence Grierson](https://scholariq.org/researchers/lawrence-grierson/)

## University top topics

Showing 8 of 25.

- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Blood Coagulation and Thrombosis Mechanisms](https://scholariq.org/topics/blood-coagulation-and-thrombosis-mechanisms/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Gastroesophageal reflux and treatments](https://scholariq.org/topics/gastroesophageal-reflux-and-treatments/)
- [Gastrointestinal motility and disorders](https://scholariq.org/topics/gastrointestinal-motility-and-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.